114 related articles for article (PubMed ID: 8417912)
41. Severe hypersensitivity reaction as acute eosinophilic pneumonia and skin eruption induced by proguanil.
Just N; Carpentier O; Brzezinki C; Steenhouwer F; Staumont-Sallé D
Eur Respir J; 2011 Jun; 37(6):1526-8. PubMed ID: 21632832
[No Abstract] [Full Text] [Related]
42. Drug interactions with antimalarial agents.
Griffin JP
Adverse Drug React Toxicol Rev; 1999 Mar; 18(1):25-43. PubMed ID: 10401521
[No Abstract] [Full Text] [Related]
43. Dapsone hypersensitivity syndrome-related lung injury without eosinophilia in the bronchoalveolar lavage fluid.
Kinehara Y; Kijima T; Inoue K; Hirata H; Takeuchi Y; Fukushima K; Hayama Y; Higashiguchi M; Morimura O; Miyake K; Minami T; Nagatomo I; Takeda Y; Kida H; Kumanogoh A
Intern Med; 2015; 54(7):827-31. PubMed ID: 25832951
[TBL] [Abstract][Full Text] [Related]
44. Pulmonary eosinophilia associated with dapsone.
Janier M; Guillevin L; Badillet G
Lancet; 1994 Apr; 343(8901):860-1. PubMed ID: 7908110
[No Abstract] [Full Text] [Related]
45. Ascertainment of risk of serious adverse reactions associated with chemoprophylactic antimalarial drugs.
Phillips-Howard PA; Bjorkman AB
Bull World Health Organ; 1990; 68(4):493-504. PubMed ID: 2208562
[TBL] [Abstract][Full Text] [Related]
46. [Granulomatous hepatitis attributed to the combination pyrimethamine-chloroquine].
van Everdingen-Bongers JJ; Janssen P; Lammens M; Stricker BH; Bravenboer B
Ned Tijdschr Geneeskd; 1996 Feb; 140(6):320-2. PubMed ID: 8720707
[TBL] [Abstract][Full Text] [Related]
47. Haemoglobinuria after a single dose treatment with dapsone and pyrimethamine for falciparum malaria in a patient with glucose-6-phosphate dehydrogenase deficiency.
Ponnampalam JT
Trop Geogr Med; 1981 Dec; 33(4):401-2. PubMed ID: 7342390
[No Abstract] [Full Text] [Related]
48. Malaria prophylaxis with doxycycline in soldiers deployed to the Thai-Kampuchean border.
Watanasook C; Singharaj P; Suriyamongkol V; Karwacki JJ; Shanks D; Phintuyothin P; Pilungkasa S; Wasuwat P
Southeast Asian J Trop Med Public Health; 1989 Mar; 20(1):61-4. PubMed ID: 2772704
[TBL] [Abstract][Full Text] [Related]
49. Reactions to dapsone.
Lancet; 1981 Sep; 2(8246):585. PubMed ID: 6116030
[No Abstract] [Full Text] [Related]
50. Elevated bronchoalveolar lavage eosinophilia correlates with poor outcome after lung transplantation.
Verleden SE; Ruttens D; Vandermeulen E; van Raemdonck DE; Vanaudenaerde BM; Verleden GM; Vos R
Transplantation; 2014 Jan; 97(1):83-9. PubMed ID: 24157472
[TBL] [Abstract][Full Text] [Related]
51. ELISA tests for dapsone and pyrimethamine and their application in a malaria chemoprophylaxis programme.
Greenwood BM; Greenwood AM; Bradley AK; Shenton FC; Smith AW; Snow RW; Williams K; Eggelte TA; Huikeshoven H; de Wit M
Bull World Health Organ; 1986; 64(6):909-16. PubMed ID: 3493860
[TBL] [Abstract][Full Text] [Related]
52. Mefloquine-induced eosinophilic pneumonia.
Katsenos S; Psathakis K; Nikolopoulou MI; Constantopoulos SH
Pharmacotherapy; 2007 Dec; 27(12):1767-71. PubMed ID: 18041895
[TBL] [Abstract][Full Text] [Related]
53. Eosinophilic pneumonia induced by dapsone.
Jaffuel D; Lebel B; Hillaire-Buys D; Pene J; Godard P; Michel FB; Blayac JP; Bousquet J; Demolyi P
BMJ; 1998 Jul; 317(7152):181. PubMed ID: 9665900
[No Abstract] [Full Text] [Related]
54. Cocaine induced eosinophilic lung disease.
Oh PI; Balter MS
Thorax; 1992 Jun; 47(6):478-9. PubMed ID: 1496510
[TBL] [Abstract][Full Text] [Related]
55. Malaria prophylaxis prescribed for travellers from New Zealand.
Leggat PA; Heydon JL; Menon A
N Z Med J; 1997 Aug; 110(1050):319-21. PubMed ID: 9315032
[TBL] [Abstract][Full Text] [Related]
56. Malaria chemoprophylaxis--which drug?
Biddulph J
P N G Med J; 1983 Jun; 26(2):127-30. PubMed ID: 6388184
[No Abstract] [Full Text] [Related]
57. [Acute eosinophilic lung after a course of minocycline].
Dussopt C; Mornex JF; Cordier JF; Brune J
Rev Mal Respir; 1994; 11(1):67-70. PubMed ID: 8128099
[TBL] [Abstract][Full Text] [Related]
58. Dapsone therapy for malaria during pregnancy: maternal and fetal outcomes.
Brabin BJ; Eggelte TA; Parise M; Verhoeff F
Drug Saf; 2004; 27(9):633-48. PubMed ID: 15230645
[TBL] [Abstract][Full Text] [Related]
59. [Eosinophilic pneumonia toxicity induced by Dapsone].
Poschenrieder F; Schulz C; Hamer OW
Rofo; 2014 Feb; 186(2):178-9. PubMed ID: 23996619
[No Abstract] [Full Text] [Related]
60. Multiple-dose pharmacokinetics and in vitro antimalarial activity of dapsone plus pyrimethamine (Maloprim) in man.
Edstein MD; Rieckmann KH; Veenendaal JR
Br J Clin Pharmacol; 1990 Aug; 30(2):259-65. PubMed ID: 2206787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
